Inventor
WENT GREGORY T
US50 patents
⚠️ This page may combine multiple inventors who share the name “WENT GREGORY T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ADAMAS PHARMACEUTICALS INC
17 patentsUS7619007B2Nov 17, 2009
Method and composition for administering an NMDA receptor antagonist to a subject
ADAMAS PHARMACEUTICALS INC53 citations98
US9072697B2Jul 7, 2015
Composition and method for treating neurological disease
ADAMAS PHARMACEUTICALS INC22 citations96
US8895615B1Nov 25, 2014
Composition and method for treating neurological disease
ADAMAS PHARMACEUTICALS INC22 citations96
US8895617B1Nov 25, 2014
Composition and method for treating neurological disease
ADAMAS PHARMACEUTICALS INC22 citations96
US8895618B1Nov 25, 2014
Composition and method for treating neurological disease
ADAMAS PHARMACEUTICALS INC22 citations96
US8895614B2Nov 25, 2014
Composition and method for treating neurological disease
ADAMAS PHARMACEUTICALS INC22 citations96
US8796337B2Aug 5, 2014
Composition and method for treating neurological disease
ADAMAS PHARMACEUTICALS INC27 citations96
US8362085B2Jan 29, 2013
Method for administering an NMDA receptor antagonist to a subject
ADAMAS PHARMACEUTICALS INC33 citations96
US8598233B2Dec 3, 2013
Method for administering an NMDA receptor antagonist to a subject
ADAMAS PHARMACEUTICALS INC21 citations93
US8580858B2Nov 12, 2013
Compositions for the treatment of CNS-related conditions
ADAMAS PHARMACEUTICALS INC22 citations93
US8987333B2Mar 24, 2015
Composition and method for treating neurological disease
ADAMAS PHARMACEUTICALS INC20 citations92
US8895616B1Nov 25, 2014
Composition and method for treating neurological disease
ADAMAS PHARMACEUTICALS INC22 citations92
US8889740B1Nov 18, 2014
Composition and method for treating neurological disease
ADAMAS PHARMACEUTICALS INC21 citations92
US7981930B2Jul 19, 2011
Compositions and kits for treating influenza
ADAMAS PHARMACEUTICALS INC22 citations91
US7858660B2Dec 28, 2010
Compositions and kits for treating influenza
ADAMAS PHARMACEUTICALS INC20 citations91
US10987324B2Apr 27, 2021
Methods and compositions for the treatment of seizure-related disorders
ADAMAS PHARMACEUTICALS INC3 citations71
US10973783B2Apr 13, 2021
Methods and compositions for the treatment of seizure-related disorders
ADAMAS PHARMACEUTICALS INC1 citations61
WENT GREGORY T
11 patentsUS8389578B2Mar 5, 2013
Composition and method for treating neurological disease
WENT GREGORY T94 citations98
US8058291B2Nov 15, 2011
Methods and compositions for the treatment of CNS-related conditions
WENT GREGORY T47 citations98
US8283379B2Oct 9, 2012
Methods and compositions for the treatment of CNS-related conditions
WENT GREGORY T33 citations96
US8168209B2May 1, 2012
Method and composition for administering an NMDA receptor antagonist to a subject
WENT GREGORY T35 citations96
US8741343B2Jun 3, 2014
Method of administering amantadine prior to a sleep period
WENT GREGORY T29 citations94
US8426472B2Apr 23, 2013
Method and composition for administering an NMDA receptor antagonist to a subject
WENT GREGORY T20 citations92
US8338485B2Dec 25, 2012
Compositions for the treatment of CNS-related conditions
WENT GREGORY T23 citations92
US8338486B2Dec 25, 2012
Methods for the treatment of CNS-related conditions
WENT GREGORY T24 citations92
US8329752B2Dec 11, 2012
Composition for administering an NMDA receptor antagonist to a subject
WENT GREGORY T24 citations92
US8293794B2Oct 23, 2012
Methods and compositions for the treatment of CNS-related conditions
WENT GREGORY T24 citations92
US8173708B2May 8, 2012
Method and composition for administering an NMDA receptor antagonist to a subject
WENT GREGORY T24 citations92
ADAMAS PHARMA LLC
11 patentsUS10646456B2May 12, 2020
Methods of administering amantadine
ADAMAS PHARMA LLC34 citations93
US9867791B2Jan 16, 2018
Method of administering amantadine prior to a sleep period
ADAMAS PHARMA LLC17 citations93
US9877933B2Jan 30, 2018
Method of administering amantadine prior to a sleep period
ADAMAS PHARMA LLC15 citations91
US9867792B2Jan 16, 2018
Method of administering amantadine prior to a sleep period
ADAMAS PHARMA LLC15 citations91
US9867793B2Jan 16, 2018
Method of administering amantadine prior to a sleep period
ADAMAS PHARMA LLC15 citations91
US10154971B2Dec 18, 2018
Methods of administering amantadine
ADAMAS PHARMA LLC8 citations83
US11903908B2Feb 20, 2024
Methods of administering amantadine
ADAMAS PHARMA LLC1 citations72
US11197835B2Dec 14, 2021
Method of administering amantadine prior to a sleep period
ADAMAS PHARMA LLC2 citations71
US11077073B2Aug 3, 2021
Methods of using amantadine compositions
ADAMAS PHARMA LLC2 citations71
US11065213B2Jul 20, 2021
Amantadine compositions and preparations thereof
ADAMAS PHARMA LLC2 citations71
US12233033B2Feb 25, 2025
Amantadine compositions, preparations thereof, and methods of use
ADAMAS PHARMA LLC0 citations60
CURAGEN CORP
10 patentsUS6236945B1May 22, 2001
Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments
CURAGEN CORP143 citations99
US6017434AJan 25, 2000
Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments
CURAGEN CORP179 citations99
US5993634ANov 30, 1999
Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments
CURAGEN CORP132 citations99
US6193866B1Feb 27, 2001
Separation of charged particles by a spatially and temporally varying electric field
CURAGEN CORP107 citations96
US6485625B1Nov 26, 2002
Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments
CURAGEN CORP100 citations95
US5938904AAug 17, 1999
Separation of charged particles by a spatially and temporally varying electric field
CURAGEN CORP81 citations95
US6150179ANov 21, 2000
Method of using solid state NMR to measure distances between nuclei in compounds attached to a surface
CURAGEN CORP27 citations93
US6341256B1Jan 22, 2002
Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination
CURAGEN CORP29 citations92
US6027941AFeb 22, 2000
Method for distance measurements with solid-state NMR
CURAGEN CORP37 citations89
US6218121B1Apr 17, 2001
Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments
CURAGEN CORP10 citations74